COMPANY
Lectenz Bio
Funding and NIH signals
- NIH award NIH awarded $1.04M (SBIR Phase II 4R44GM159548-02, extension, notice Aug 24, 2026). NIH RePORTER 4R44GM159548-02 (Aug 24, 2026)
Evidence (1 event)
- Aug 24, 2026 · NIH RePORTER 4R44GM159548-02
Organization: LECTENZ BIO, INC.; City/State: ATHENS, GA; Project number: 4R44GM159548-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-24; FY total cost (award amount): 1044652; Administering IC: National Institute of General Medical Sciences; Project title: Innovative glycan-specific reagents to accelerate the detection of disease biomarkers; Organization type: Domestic For-Profits
- Aug 24, 2026 · NIH RePORTER 4R44GM159548-02
Timeline
- Grant Government grant — SBIR: $1.04M (annual award, as published), announced Aug 24, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
- Grant Government grant — SBIR: $999,973 (annual award, as published), announced Aug 18, 2025. Agency: NIH/OD. Source: government award database. source ↗
- Grant Government grant — SBIR: $313,827 (annual award, as published), announced Jul 18, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
Funding
- Government grant — SBIR: $1.04M (annual award, as published), announced Aug 24, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
- Government grant — SBIR: $999,973 (annual award, as published), announced Aug 18, 2025. Agency: NIH/OD. Source: government award database. source ↗
- Government grant — SBIR: $313,827 (annual award, as published), announced Jul 18, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
NIH awards 33
- NIH award 4R44OD035390-02 FY2024: $1,018,214 awarded for that fiscal year; activity R44 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Engineered Pan-Specific Reagents for N-Glycan D source ↗
- NIH award 5R44GM153145-02 FY2024: $984,227 awarded for that fiscal year; activity R44 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. A new approach to monitoring glycosylation during g source ↗
- NIH award 3R44GM153145-01S1 FY2024: $34,699 awarded for that fiscal year; activity R44 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. A new approach to monitoring glycosylation during source ↗
- NIH award 1R44GM153145-01 FY2023: $988,601 awarded for that fiscal year; activity R44 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. A new approach to monitoring glycosylation during g source ↗
- NIH award 1R44OD035390-01A1 FY2023: $301,703 awarded for that fiscal year; activity R44 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Engineered Pan-Specific Reagents for N-Glycan D source ↗
- NIH award 3R44OD024964-03S1 FY2022: $37,200 awarded for that fiscal year; activity R44 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Pan-specific tools and reagents for the enrichme source ↗
- NIH award 5R44OD024964-03 FY2021: $740,575 awarded for that fiscal year; activity R44 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Pan-specific tools and reagents for the enrichmen source ↗
- NIH award 5R43GM135984-02 FY2021: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Development of a suite of high-specificity fucose b source ↗
- NIH award 5R43GM136013-02 FY2021: $222,795 awarded for that fiscal year; activity R43 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Novel Reagents for Monitoring Sulfation Patterns source ↗
- NIH award 4R44OD024964-02 FY2020: $740,575 awarded for that fiscal year; activity R44 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Pan-specific tools and reagents for the enrichmen source ↗
- NIH award 1R43GM136013-01 FY2020: $224,996 awarded for that fiscal year; activity R43 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Novel Reagents for Monitoring Sulfation Patterns source ↗
- NIH award 5R44GM113351-05 FY2020: $349,995 awarded for that fiscal year; activity R44 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. High-specificity affinity reagents for the detectio source ↗
- NIH award 1R43GM135984-01 FY2020: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Development of a suite of high-specificity fucose b source ↗
- NIH award 5U01CA221213-03 FY2019: $278,800 awarded for that fiscal year; activity U01 (OTHER_NIH); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Adapting multiplex microspheres to analyze gly source ↗
- NIH award 3R43GM123856-02S1 FY2019: $55,000 awarded for that fiscal year; activity R43 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Reagents specific for all N-glycans source ↗
- NIH award 5R44GM113351-04 FY2019: $349,932 awarded for that fiscal year; activity R44 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. High-specificity affinity reagents for the detectio source ↗
- NIH award 5R43GM123863-02 FY2018: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. A rapid method for monitoring in vitro glycoenginee source ↗
- NIH award 1R44OD024964-01 FY2018: $224,934 awarded for that fiscal year; activity R44 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Pan-specific tools and reagents for the enrichmen source ↗
- NIH award 5R43GM123856-02 FY2018: $224,944 awarded for that fiscal year; activity R43 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Reagents specific for all N-glycans source ↗
- NIH award 5U01CA221213-02 FY2018: $278,800 awarded for that fiscal year; activity U01 (OTHER_NIH); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Adapting multiplex microspheres to analyze gly source ↗
- NIH award 2R44GM113351-03 FY2018: $349,980 awarded for that fiscal year; activity R44 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. High-specificity affinity reagents for the detectio source ↗
- NIH award 1R43GM123863-01 FY2017: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. A rapid method for monitoring in vitro glycoenginee source ↗
- NIH award 1R43GM123856-01A1 FY2017: $224,944 awarded for that fiscal year; activity R43 (SBIR); PI WU, SHENG-CHENG; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Reagents specific for all N-glycans source ↗
- NIH award 1U01CA221213-01 FY2017: $278,800 awarded for that fiscal year; activity U01 (OTHER_NIH); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. Adapting multiplex microspheres to analyze gly source ↗
- NIH award 5R41GM113351-02 FY2016: $349,282 awarded for that fiscal year; activity R41 (STTR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. High-specificity affinity reagents for the detectio source ↗
- NIH award 5R42GM086991-04 FY2015: $591,235 awarded for that fiscal year; activity R42 (STTR); PI WOODS, ROBERT J; recipient as written: LECTENZ BIO, INC., ATHENS, GA. High-specificity affinity reagents for N-glycosyl source ↗
- NIH award 1R41GM113351-01 FY2015: $348,875 awarded for that fiscal year; activity R41 (STTR); PI YANG, LORETTA; recipient as written: LECTENZ BIO, INC., ATHENS, GA. High-specificity affinity reagents for the detectio source ↗
- NIH award 5R42GM086991-03 FY2014: $589,209 awarded for that fiscal year; activity R42 (STTR); PI WOODS, ROBERT J; recipient as written: LECTENZ BIO, INC., ATHENS, GA. High-specificity affinity reagents for N-glycosyl source ↗
- NIH award 2R42GM086991-02A1 FY2013: $547,745 awarded for that fiscal year; activity R42 (STTR); PI WOODS, ROBERT J; recipient as written: LECTENZ BIO, INC., ATHENS, GA. High-specificity affinity reagents for N-glycos source ↗
- NIH contract (government contract; not a grant and not an investment round) 261201300048C-0-0-1 FY2013: $999,970 awarded for that fiscal year; activity N44 (OTHER_NIH); PI YANG, LORI; recipient as written: LECTENZ BIO, INC., ATHENS, GA. DEVELOPMENT OF RESEARCH source ↗